ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Parasite and Host
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1648268
BALB/c mice infection with hybrid Leishmania (V.) guyanensis/L. (V.) shawi showed an intermediate virulence profile compared to parental species infections
Provisionally accepted- 1Laboratório de Patologia de Moléstias Infecciosas (LIM50), Departamento de Patologia, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil
- 2Secretaria de Vigilância da Saúde, Ministério da Saúde, Instituto Evandro Chagas, Ananindeua, Brazil
- 3Universidade Federal do Amapa Departamento de Ciencias Biologicas e da Saude, Macapá, Brazil
- 4Instituto de Biociências, Universidade de Sao Paulo, São Paulo, Brazil
- 5Núcleo de Medicina Tropical, Universidade Federal do Para, Belém, Brazil
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Hybridization events within the genus Leishmania have been documented; however, their impact on the infection dynamics of hybrids remains poorly understood. In this study, we compared the infection dynamics caused by a hybrid parasite, Leishmania (Viannia) guyanensis/Leishmania (Viannia) shawi, with those caused by its parental species, Leishmania (Viannia) guyanensis and Leishmania (Viannia) shawi, in BALB/c mice. To this end, Balb/c mice were inoculated with stationary-phase promastigote forms of each parasite. Lesion development and parasite load were monitored longitudinally, and cytokine production was assessed at 35 days post-infection (PI). Our results showed that infection with the hybrid parasite induced a more rapid and evident progression, attaining its largest dimension between days 14 and 28 days PI, followed by regression. In contrast, infection with L. (V.) guyanensis resulted in a continuous increase in swelling, whereas L. (V.) shawi caused only mild swelling. Parasite loads in skin and lymph nodes were comparable across groups, though the hybrid parasite exhibited a significant increase in parasite burden from day 35 PI onwards. The immunologic response of hybrid parasite infection was associated with reduced gamma interferon (IFN-γ) and elevated interleukin 4 (IL-4) production compared to parental species and controls (P < 0.05), with no significant differences observed in interleukin 12 (IL-12p40) or interleukin 10 (IL-10). Infection with L. (V.) guyanensis led to decreased IFN-γ in lymph nodes and increased IL-4 production in both skin and lymph nodes, whereas L. (V.) shawi infection did not significantly alter cytokine profiles. Together, these findings provide important insights into the distinct biological behavior of the Leishmania hybrid parasite and its parental species, underscoring the relevance of hybridization in shaping host-parasite interactions and advancing our understanding of leishmaniasis within complex eco-epidemiological settings.
Keywords: cutaneous leishmaniasis, L. (V.) guyanensis, L. (V.) shawi, Biological behavior, hybrid parasite
Received: 16 Jun 2025; Accepted: 11 Aug 2025.
Copyright: © 2025 Lima, Tomokane, Rodrigues, Alcântara, Campos, Pombo, Laurenti, da Matta, Floeter-Winter, Corbett, Silveira and Gomes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ana Carolina Stocco Lima, Laboratório de Patologia de Moléstias Infecciosas (LIM50), Departamento de Patologia, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.